SWAV - ShockWave Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
859.02M
Enterprise Value 3
716.65M
Trailing P/E
N/A
Forward P/E 1
-20.30
PEG Ratio (5 yr expected) 1
-0.24
Price/Sales (ttm)
33.11
Price/Book (mrq)
7.19
Enterprise Value/Revenue 3
27.62
Enterprise Value/EBITDA 6
-16.41

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 36.81%
52 Week High 368.39
52 Week Low 324.58
50-Day Moving Average 333.68
200-Day Moving Average 344.25

Share Statistics

Avg Vol (3 month) 3418.9k
Avg Vol (10 day) 3341.38k
Shares Outstanding 528.03M
Float 21M
% Held by Insiders 143.58%
% Held by Institutions 144.89%
Shares Short (Sep 30, 2019) 42.15M
Short Ratio (Sep 30, 2019) 42.97
Short % of Float (Sep 30, 2019) 410.25%
Short % of Shares Outstanding (Sep 30, 2019) 47.69%
Shares Short (prior month Aug 30, 2019) 42.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -172.71%
Operating Margin (ttm)-171.97%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)25.94M
Revenue Per Share (ttm)2.53
Quarterly Revenue Growth (yoy)339.30%
Gross Profit (ttm)5.01M
EBITDA -43.68M
Net Income Avi to Common (ttm)-44.81M
Diluted EPS (ttm)-4.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)125.14M
Total Cash Per Share (mrq)4.47
Total Debt (mrq)17.8M
Total Debt/Equity (mrq)14.91
Current Ratio (mrq)9.13
Book Value Per Share (mrq)4.26

Cash Flow Statement

Operating Cash Flow (ttm)-44.63M
Levered Free Cash Flow (ttm)N/A